pharmaphorum

MARCH 21, 2024

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, co-founder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about the often unseen difficulties of validating a digital therapeutic through a clinical trial.

114

114

pharmaphorum

APRIL 6, 2022

Ensuring that patients remain consistent with their therapies is one of the major challenges facing healthcare, so what if you could make treatment a game? That’s the potential behind game-based digital therapeutics and it’s drawing a lot of interest, finds Ben Hargreaves. Adding a unique clinical tool.

FDA 108

FDA 108

pharmaphorum

NOVEMBER 23, 2022

Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges. Many will also face barriers to care, where access to specialists is limited and often geographically out of reach. Consultations and clinical trials are often few and far between.

Communication 109

Communication 109

pharmaphorum

NOVEMBER 2, 2020

Most of the digital health experts we spoke to for this issue of Deep Dive made one thing clear – no one can really say what the future holds for digital tech in the pharma and healthcare industries. The key elements driving the success of digital health. A “pivotal moment” for digital health adoption.

Pharmaceutical Companies 58

Pharmaceutical Companies Pharmaceutical Companies 58

European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Advising companies, he emphasised that those “manufacturing cannabis-based medicines should not underestimate the scale of the challenge.” It really comes down to a number of factors.

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceutical Companies Compounding 130

pharmaphorum

OCTOBER 26, 2022

Chiesi’s approach to these trials presents a clear demonstration of Chiesi’s patient-centricity approach in action. But rare diseases are a particularly important and challenging focus area. These results highlight the need to invest in therapeutic innovation as well as diagnostics and newborn screening.

Patient Care 82

Patient Care FDA 82

PharmaShots

JANUARY 23, 2023

The specific mechanisms by which VTAMA cream exerts its therapeutic action in psoriasis patients are unknown. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. of VTAMA cream?

FDA 40

FDA Labelling Immunization 40